Pinnacle Financial Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $4.53M | Buy |
9,354
+3,158
| +51% | +$1.53M | 0.09% | 176 |
|
|
2024
Q4 | $2.5M | Sell |
6,196
-445
| -7% | -$179K | 0.05% | 209 |
|
|
2024
Q3 | $3.09M | Buy |
6,641
+6,029
| +985% | +$2.8M | 0.06% | 192 |
|
|
2024
Q2 | $287K | Buy |
612
+20
| +3% | +$9.37K | 0.01% | 376 |
|
|
2024
Q1 | $247K | Sell |
592
-50
| -8% | -$20.9K | 0.01% | 399 |
|
|
2023
Q4 | $261K | Buy |
+642
| New | +$261K | 0.01% | 376 |
|
|
2023
Q3 | – | Sell |
-600
| Closed | -$211K | – | 568 |
|
|
2023
Q2 | $211K | Buy |
+600
| New | +$211K | 0.01% | 381 |
|
|
2022
Q1 | – | Sell |
-1,039
| Closed | -$229K | – | 484 |
|
|
2021
Q4 | $229K | Buy |
+1,039
| New | +$229K | 0.01% | 367 |
|
|
2021
Q2 | – | Sell |
-933
| Closed | -$200K | – | 482 |
|
|
2021
Q1 | $200K | Sell |
933
-84
| -8% | -$18K | 0.01% | 339 |
|
|
2020
Q4 | $240K | Sell |
1,017
-304
| -23% | -$71.7K | 0.01% | 325 |
|
|
2020
Q3 | $360K | Buy |
1,321
+6
| +0.5% | +$1.64K | 0.02% | 268 |
|
|
2020
Q2 | $382K | Buy |
+1,315
| New | +$382K | 0.02% | 256 |
|